Glympse Bio’s work on multiplexed protease sensors for urinary monitoring of nonalcoholic steatohepatitis was published in Science Translational Medicine! Congratulations to Gabe and the team! Read the full manuscript here.
Summary | Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease that has been dubbed the silent epidemic as it has few symptoms. When left undiagnosed and untreated, the liver can develop cirrhosis or liver cancer. We developed synthetic biomarkers to diagnosis NASH early, monitor changes in disease severity, and indicate response to treatment.